The partnership will utilize the Indiana Network for Patient Care and the Regenstrief Notifiable Condition Detector to get data from EHRs on the prevalence of long COVID-19 symptoms, according to a Sept. 7 Regenstrief news release. Researchers will also enroll adults and children with recent infections to study the disease course and outcomes.
“Long COVID conditions include a wide range of serious health consequences that occur more than four weeks after initial viral infection. Clinicians seek to know more about them and what to expect when patients show up with them for treatment,” said Shaun Grannis, MD, Regenstrief vice president for data and analytics. “Anecdotal information about long COVID abounds, but what we need is accurate, comprehensive scientific evidence. Our study will provide critical information for public health, patients and the clinicians who care for people with long COVID.”
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
